SS-31 (Elamipretide): Mitochondrial Inner Membrane Stabilization, Cardiolipin Binding, and ATP Bioenergetics
A structural and biochemical investigation into SS-31 (Elamipretide). Szeto-Schiller peptide cell permeability, selective cardiolipin electrostatic interaction, complex IV stabilization, and ROS scavenging. SS-31 is an engineered Szeto-Schiller tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) with alternating aromatic-basic motifs.
- SS-31 is an engineered Szeto-Schiller tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) with alternating aromatic-basic motifs.
- Selectively targets the inner mitochondrial membrane (IMM) without relying on mitochondrial membrane potential.
- Binds electrostatically and hydrophobically to cardiolipin, preventing cardiolipin peroxidation and cytochrome c detachment.
- Restores electron transport chain efficiency, boosts ATP production, and reduces reactive oxygen species (ROS) in cell culture.
| CAS Registry Number | 736992-21-5 |
|---|---|
| Molecular Formula | C32H49N9O5 |
| Molecular Mass | 639.80 g/mol |
| Primary Biological Target | Mitochondrial Cardiolipin & Electron Transport Complexes I-IV |
| Analytical Purity Standard | ≥99.0% (RP-HPLC, C18, 214/220 nm) |
| Identity Verification | ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%) |
| Lyophilized Storage | -20°C desiccated, protected from UV light (24–36 months) |
| Reconstituted Storage | 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water) |
1. Szeto-Schiller Architecture and Cell Permeability
SS-31 (Elamipretide, MTP-131) belongs to the Szeto-Schiller (SS) family of synthetic peptides designed to overcome the permeability barriers of cellular and mitochondrial membranes. Its structure is H-D-Arg-Dmt-Lys-Phe-NH2 (where Dmt is 2',6'-dimethyltyrosine). The sequence alternates aromatic residues (Dmt, Phe) with basic positively charged residues (D-Arg, Lys) capped with a C-terminal amide. This structural motif balances lipophilicity with positive charge, allowing SS-31 to cross lipid bilayers via non-endocytic passive diffusion within minutes.
2. High-Affinity Cardiolipin Interaction at the Inner Membrane
Cardiolipin is a unique tetra-acyl phospholipid localized almost exclusively in the inner mitochondrial membrane (IMM). Cardiolipin anchors respiratory chain complexes (I, III, IV) into high-efficiency supercomplexes (respirasomes) and binds cytochrome c. In aging and ischemic stress models, cardiolipin undergoes reactive oxidation, disintegrating respirasomes. Isothermal titration calorimetry (ITC) proves that SS-31 binds cardiolipin with high affinity (Kd ≈ 1.5 µM), shielding cardiolipin from free radical peroxidation and maintaining optimal cristae curvature.
3. Electron Transport Supercomplex Optimization and ROS Quenching
By stabilizing cardiolipin-protein interfaces, SS-31 enhances electron transfer through Complex IV (cytochrome c oxidase) and Complex I (NADH dehydrogenase). This structural stabilization minimizes electron leakage at Complex I/III, drastically lowering mitochondrial superoxide and hydrogen peroxide (H2O2) generation while elevating cellular ATP synthesis rates by up to 35% in stressed myocyte and cardiomyocyte cultures.
4. Laboratory Preparation and Solubility
SS-31 is supplied as a high-purity acetate or TFA salt. Due to its basic residues, it dissolves rapidly in sterile Bacteriostatic Water, 0.9% sodium chloride, or standard assay buffers (pH 6.5–7.5). Solutions should be aliquoted and stored at -20°C for long-term experimental series, avoiding repeated freeze-thaw cycles.
5. Bench Preparation & Assay Reproducibility for SS-31 (Elamipretide)
When designing in-vitro experiments targeting Mitochondrial Cardiolipin & Electron Transport Complexes I-IV, normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (639.80 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.
Peer-Reviewed References & Analytical Standards
- Szeto H.H. (2014). First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology, 171(8), 2029–2050. [PMID: 24117156 ↗]
- Birk A.V. et al. (2013). The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology, 24(8), 1250–1261. [PMID: 23813215 ↗]
Referenced Laboratory Research Reagents
Batch-verified SwissLab catalog entries cited in this monograph
All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.